ADPT R&D to Revenue
Adaptive Biotechnologies Corp · R&D to Revenue
ADPT R&D to Revenue
Latest reported26.77%period ending
ADPT Quarterly R&D/Revenue (91.15% → 26.77%)
Latest values, visible window
High-resolution chart · PNG
ADPT r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 26.7676% | |
| 33.331% | |
| 30.3609% | |
| 25.187% | |
| 40.9891% | |
| 46.1511% | |
| 48.8674% | |
| 52.0362% | |
| 58.7011% | |
| 72.2303% | |
| 62.7861% | |
| 75.2472% | |
| 65.8893% | |
| 86.5965% | |
| 56.5636% | |
| 74.5515% | |
| 84.8305% | |
| 97.9777% | |
| 91.4817% | |
| 91.3979% | |
| 98.1691% | |
| 87.8518% | |
| 118.7047% | |
| 115.2667% | |
| 123.8422% | |
| 114.4668% | |
| 87.5253% | |
| 78.6937% | |
| 74.6544% | |
| 98.5552% | |
| 64.373% | |
| 56.9176% | |
| 81.7082% | |
| 91.1477% |